Saskatoon, Saskatchewan, Canada
April 14, 2009
Trevor Thiessen has been appointed
new President of the BioAg line of business in
Novozymes Biologicals,
manufacturer of inoculants JumpStart®, TagTeam® and N-Prove®.
Trevor Thiessen takes over from Calvin Sonntag who has decided
upon a career move outside of Novozymes.
Ted Melnik, President of the parent Novozymes Biologicals based
in Salem, VA says: “Picking the right leader for the business is
the most important thing that I can do. It is gratifying that I
didn’t have to look very far. I am very pleased to announce the
promotion of Trevor Thiessen to President of the BioAg line of
business in Novozymes Biologicals worldwide”.
After graduating with a B. Comm. in [1993] from the University
of Saskatchewan Trevor Thiessen joined the predecessor of the
BioAg business, namely Philom Bios, and subsequently earned his
MBA from the University of Saskatchewan. After a few years in
the canola seed industry, Trevor, rejoined the company in 2002
as Marketing Manager and since then has held increasingly senior
roles overseeing marketing, sales, production, and research
activities.
“Over the last year and a half we have invested in the BioAg
business in a number of ways. We have expanded the organization,
developed new products and invested at the Saskatoon site. In
short we are excited about what has been accomplished so far and
we enthusiastically look ahead to the future,” says Ted Melnik.
BioAg is a line of business within Novozymes – the world
leader in bioinnovation. Our vision is to use microbial-based
solutions to help the world’s farmers produce more and better
food, feed, fuel, and fibre while minimizing the environmental
footprint of production agriculture. Headquartered in Saskatoon,
SK, Canada, the BioAg business has over 100 employees in
research, manufacturing, marketing, and management in North
America, South America, Asia, Europe, and in joint-venture
operations in Australia. For over 28 years, we have been
committed to farmers through a dynamic partnership with
distributors and leading retailers. Read more at
www.bioag.novozymes.com.
Novozymes is the world leader in bioinnovation. Together with
customers across a broad array of industries, we create
tomorrow’s industrial biosolutions, improving our customers'
business, and the use of our planet's resources.
With over 700 products used in 130 countries, Novozymes’
bioinnovations improve industrial performance and safeguard the
world’s resources by offering superior and sustainable solutions
for tomorrow’s ever-changing marketplace.
Novozymes’ natural solutions enhance and promote everything from
removing trans-fats in food, to advancing biofuels to power the
world tomorrow. Our never-ending exploration of nature’s
potential is evidenced by over 5,000 patents, showing what is
possible when nature and technology join forces.
Our 5,000+ employees working in research, production and sales
around the world are committed to shaping business today and our
world tomorrow.
Novozymes is quoted on NASDAQ OMX Copenhagen A/S. Read more at
www.novozymes.com. |
|
